🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
Mineral Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Calcium
500 mg (50% DV)

Other Ingredients

Microcrystalline Cellulose Acacia Maltodextrin Croscarmellose Sodium Hypromellose Titanium Dioxide Soy Polysaccharides Sodium Lauryl Sulfate Talc Triacetin Stearic Acid Mineral Oil Riboflavin FD&C Blue No. 1 Lake

Label Claims — Verification

Nutrient
All Other
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: For adults, take one (1) tablet daily as a dietary supplement preferably with a meal.

⚠️ Warnings & Precautions

Contains: Soy and shellfish (oyster) ingredients.

Keep this and all medication out of the reach of children.

Do not use if blister unit is broken

Calcium and other minerals can affect the absorption of many medications. Do not take this product within 2 hours of taking medications. As a reminder, discuss the supplements and medications you take with your health care providers and follow their advice. Warning: Pregnant or lactating women should consult a doctor before using any product.

Avoid this product if you have allergies to shellfish or a history of kidney stones.

Consult your doctor before use if you have, or had any health condition or if you are taking any medications or remedies, including OTC medications, or are planning any medical procedure.

Discontinue use and consult your doctor if any adverse reactions occur, such as gastrointestinal discomfort.

Not intended for use by persons under the age of 18.

🧪 Formulation Notes

Oyster Shell Calcium (Elemental) Supplement Contains: Soy and shellfish (oyster) ingredients.

Additional Information

Unit Dose

Store at 20(0)-25(0)C (68(0)-77(0)F); excursions permitted to 15(0)-30(0)C (59(0)-86(0)F). [See USP Controlled Room Temperature]

Re-Order No. 301827 M-29 Rev. 06/17 10196-06-17

Product Details

UPC / SKU 3 09041 88361 1
DSLD Entry Date 2019-04-25
Product Type Mineral
Form Tablet or Pill
DSLD ID 201733
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →